Literature DB >> 11697218

Molecular genetics of ovarian cancer.

A N Shelling1, W Foulkes.   

Abstract

This is a review of the approaches that can be used to analyze genetic changes in ovarian cancer. Traditional gene localization methods are discussed, followed by a section on gene identification techniques. Once a putative disease-associated gene has been cloned, mutations have to be identified and analyzed. There are numerous mutation detection methods, and the most common ones are outlined. In the penultimate section, the role of immunohistochemistry as a surrogate method for mutation analysis is considered. Finally, the possible use of functional assays is discussed. At present, it would appear that DNA chip technology for the detection of mutations, and microarray analysis of gene expression, are two important techniques likely to have a significant impact on the genetic analysis of ovarian cancer.

Entities:  

Mesh:

Year:  2001        PMID: 11697218     DOI: 10.1385/MB:19:1:013

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  62 in total

1.  Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization.

Authors:  N G Wolf; F W Abdul-Karim; C Farver; E Schröck; S du Manoir; S Schwartz
Journal:  Genes Chromosomes Cancer       Date:  1999-08       Impact factor: 5.006

2.  Contribution of BRCA1 mutations to ovarian cancer.

Authors:  J F Stratton; S A Gayther; P Russell; J Dearden; M Gore; P Blake; D Easton; B A Ponder
Journal:  N Engl J Med       Date:  1997-04-17       Impact factor: 91.245

3.  Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer.

Authors:  I E Cooke; A N Shelling; V G Le Meuth; M L Charnock; T S Ganesan
Journal:  Genes Chromosomes Cancer       Date:  1996-04       Impact factor: 5.006

4.  Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells.

Authors:  V M Wasenius; A Jekunen; O Monni; H Joensuu; S Aebi; S B Howell; S Knuutila
Journal:  Genes Chromosomes Cancer       Date:  1997-04       Impact factor: 5.006

5.  Identification by cDNA microarray of genes involved in ovarian carcinogenesis.

Authors:  K Ono; T Tanaka; T Tsunoda; O Kitahara; C Kihara; A Okamoto; K Ochiai; T Takagi; Y Nakamura
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

6.  Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlations.

Authors:  G Chenevix-Trench; J Kerr; T Hurst; Y C Shih; D Purdie; L Bergman; M Friedlander; B Sanderson; A Zournazi; T Coombs; J A Leary; E Crawford; A N Shelling; I Cooke; T S Ganesan; J Searle; C Choi; J C Barrett; S K Khoo; B Ward
Journal:  Genes Chromosomes Cancer       Date:  1997-02       Impact factor: 5.006

7.  Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region.

Authors:  M Schutte; L T da Costa; S A Hahn; C Moskaluk; A T Hoque; E Rozenblum; C L Weinstein; M Bittner; P S Meltzer; J M Trent
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

8.  Genetic analysis of benign, low-grade, and high-grade ovarian tumors.

Authors:  H Iwabuchi; M Sakamoto; H Sakunaga; Y Y Ma; M L Carcangiu; D Pinkel; T L Yang-Feng; J W Gray
Journal:  Cancer Res       Date:  1995-12-15       Impact factor: 12.701

9.  Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

Authors:  S D Merajver; T M Pham; R F Caduff; M Chen; E L Poy; K A Cooney; B L Weber; F S Collins; C Johnston; T S Frank
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

10.  p53 gene mutations and protein accumulation in human ovarian cancer.

Authors:  J Kupryjańczyk; A D Thor; R Beauchamp; V Merritt; S M Edgerton; D A Bell; D W Yandell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.